GUIDELINES FOR THE CLASSIFICATION OF GENETICALLY MODIFIED MICRO-ORGANISMS INTO GROUP I ACCORDING TO ARTICLEGuidelines for the classification of genetically modified micro-organisms into Group I according to Article 4 (3) OF DIRECTIVE 90/129of Directive 90/219/EEC
For classification of GMMs into Group I, the following guidelines should be used for the further interpret interpretation of the criteria established by Annex II of Directive 90/219/EEC:
A. Characteristics of the recipient or parental organism(s) 1. Non-pathogenic The recipient or parental organisms can be classified as non-pathogenic if they satisfy the conditions of one of the following paragraphs: (i) the recipient or parental strain should have an established record of safety in the laboratory and/or industry, with no adverse effects on human health and the environment; (ii) the , and for the further development by competent authorities of more detailed guidelines aimed at specific cases:
1. Criteria (i) — (iii) refer to immunocompetent humans and healthy animals or plants.
2. As regards criterion (i) of Annex II, the following guidelines are given:
(a) in deciding whether the recipient or parental strain does not meet the conditions of paragraph (i) but it belongs to a species for which there is a long record of biological work including safety in the lab and/or industry, showing no adverse effects on human health and the environment; (iii) if the recipient or parental organism is a strain which does not satisfy the conditions of paragraph (i) and belongs to a species for which there is no micro-organism is likely to cause disease to animals or plants consideration should be given to the environment likely to be exposed to the recipient or parental micro-organism;
(b) non-virulent strains of acknowledged pathogenic species could be considered as unlikely to cause disease and as satisfying criterion (i) in Annex II, provided that:
(i) the non-virulent strain has an established record of biological work including safe use safety in the laboratory and/or industry, appropriate testing (including, if necessary, animals) must be carried out, in order to establish non-pathogenicity and safety in the environment; (iv) if a non-virulent with no adverse effects on human, animal or plant health;
and/or
(ii) the strain of an acknowledged pathogenic species is used, the strain should be as is stably deficient as possible in genetic material that determines virulence so as to ensure no reversion to pathogenicity. In the case of bacteria, special attention should be given to plasmid or phage-borne , or has stable mutations known to sufficiently reduce virulence.
When it is not essential to remove all virulence determinants. 2. No adventitious agents The recipient or parental strain/cell line from a pathogen, particular attention should be free of known biological contaminating agents (symbionts, mycoplasma, viruses, viroids, etc.), which are potentially harmful. 3. The recipient or parental strain/cell line should have proven and extended history of safe use or built-in biological barriers, which, without interfering with optimal growth in the reactor or fermentor, confer limited survivability and replicability, without adverse consequences in the environment (applicable only for type B operations). B.1. Characteristics of the vector 1.1. paid to any toxin genes, plasmid- or phageborne virulence determinants and harmful adventitious agents. On such occasions a case by case evaluation will be needed.
3. As regards criterion (ii) of Annex II, the following guidelines are given:
(a) The vector/insert should be well characterized For this purpose the following characteristics should be taken into account. 1.1.1. Information on composition and construction (a) The type of the vector should be defined (virus, plasmid, cosmid, phasmid, transposable element, minichromosome, etc.); (b) The following information on the constituent fragments of the vector should be available: (i) the origin of each fragment (progenitor genetic element, strain of organism in which the progenitor genetic element naturally occurred); (ii) if some fragments are synthetic, their function should be known. (c) The methods used for construction should be known. 1.1.2. Information on vector structure (a) The size of not contain genes expressing an active protein or transcript (e. g. virulence determinants, toxins, etc.) at a level and in a form which endow the genetically modified micro-organism with a phenotype likely to cause disease to humans, animals or plants.
In any case, when the vector/insert contains sequences which are involved in the expression of harmful traits in certain micro-organisms, but which do not endow the GMM with a phenotype likely to cause disease to humans, animals or plants, or likely to cause adverse effects on the environment, then the vector/insert should be known and expressed in basepairs or D. (b) The function and relative position of the following should be known: (i) structural genes; (ii) marker genes for selection (antibiotic resistance, heavy metal resistance, phage immunity, genes coding for degradation of xenobiotics, etc.); (iii) regulatory elements; (iv) target sites (nic-sites, restriction endonuclease sites, linkers, etc.); (v) transposable elements (including provirus not be self-transmissible and should be poorly mobilizable.
(b) In the case of Type B operations, special consideration should be given to the following:
— vectors should not be self-transmissible or contain functional transposing sequences); (vi) genes related to transfer and mobilization function (e.g. with respect to conjugation, transduction or chromosomal integration); (vii) replicon(s) 1.2. The vector should be free from harmful sequences The vector should not contain genes coding for potentially harmful or pathogenic traits (e.g. virulence determinants, toxins, etc.), (unless, for type A operations, such genes constitute an essential feature of ; and should be poorly mobilizable,
— in deciding whether the vector/insert is likely to endow the genetically modified micro-organism with a phenotype likely to cause disease to humans, animals or plants or to cause adverse effects in the environment, it is important to ensure that the vector without, under any conditions or circumstances, resulting in a harmful or pathogenic phenotype of the genetically modified micro-organism). 1.3. The vector should be /insert is well characterized or limited in size as much as possible to the genetic sequences required to perform the intended function. 1.4. The vector should not increase the stability of the genetically modified micro-organism in the environment (unless that is a requirement of the intended function). 1.5. The vector should be poorly mobilizable 1.5.1. If the vector is a plasmid: (i) it should have a restricted host-range; (ii) it
4. As regards criterion (iii) of Annex II, the following guidelines are given:
(a) in deciding whether the gentically modified micro-organism is likely to cause adverse effects on the environment or disease to animals or plants, consideration should be defective in transfer-mobilization factors e.g. Tra , Mob+, for type A operations or Tra , Mob , for given to the environment likely to be exposed to the GMMs.
(b) in the case of type B operations. 1.5.2. If the vector is a virus, cosmid, or phasmid: (i) it should have a restricted host range; (ii) it, in addition to criterion (iii), consideration should be rendered non-lysogenic when used as a cloning vector (e.g. defective in the CI-lamda repressor). 1.6. It given to the following:
— the genetically modified micro-organism should not transfer any resistance markers to micro-organisms not known to acquire them naturally (, if such acquisition could transfer compromise use of drug to control disease agents) B.2. Required characteristics of the insert 2.1. The insert treatment;
— the genetically modified micro-organism should be well characterized For this purpose, the following characteristics should be taken into account: 2.1.1. The origin of the insert should be known (genus, species, strain). 2.1.2. The following information on the library from which the insert originated, should be known: (i) the source and method for obtaining the nucleic acid of interest (cDNA, chromosomal mitochondrial, etc.); (ii) the vector in as safe in the industrial setting as the recipient or parental micro-organism, or have characteristics that limit survival and gene transfer.
(c) other GMMs which the library was constructed (e.g. lamda GT 11, pBR 322, etc.) and the site in which the DNA was inserted; (iii) the method used for identification (colony, hybridization, immuno-blot, etc.); (iv) the strain used for library construction. 2.1.3. If the insert is synthetic, its intended function should be identified. 2.1.4. The following information on the structure of the insert is required: (i) information on structural genes, regulatory elements; (ii) size of the insert; (iii) restriction endonuclease sites flanking the insert; (iv) information on transposable elements and provirus sequences. 2.2. The insert should be free could be included in Group I if they are without adverse effects on the environment and meet the conditions in Annex II (i) are those that are constructed entirely from a single prokaryotic recipient (including its indigenous plasmids, transposons and viruses), or from harmful sequences (i) The function of each genetic unit in the insert should be defined (not applicable for type A operations); (ii) the insert should not contain genes coding for potential pathogenic traits (e.g. virulence determinants, toxins, etc.), (unless for type A operations, such genes constitute an essential part of the insert without, under any circumstances resulting in a harmful or pathogenic phenotype of the genetically modified micro-organism). 2.3. The insert should be limited in size as much as possible to the genetic sequences required to perform the intended function. 2.4. The insert should not increase the stability of the construct in the environment (unless that is a requirement of intended function). 2.5. The insert should be poorly mobilizable For instance, it should not contain transposing or transferrable provirus sequences and other functional transposing sequences. C. Required characteristics of the genetically modified micro-a single eukaryotic recipient (including its chloroplasts, mitochondria, plasmids, but excluding viruses), or consist entirely of genetic sequences from different species that exchange these sequences by known physiological processes.
Before deciding if these GMMs are to be included in Group I it should be considered whether they are excluded from the Directive under the provisions of Annex I B (4), taking into account that self-cloning means the removal of nucleic acid from a cell of an organism 1. The genetically modified micro-organism should be non-pathogenic This requirement is reasonably assured by compliance with all the requirements above. 2. (a) The genetically modified micro-organism should be as safe (to man and the environment) as the recipient or parental strains) (applicable only for type A operations). (b) The genetically modified micro-organisms should be as safe in the reactor or fermentor as the recipient or parental strains, but , followed by reinsertion of all or part of that nucleic acid — with limited survivability and/or replicability outside the reactor or fermentor without adverse consequences in the environment (applicable only for or without further enzymic chemical or mechanical steps — into the same cell type B operations). D. Other genetically modified micro-organisms that could be included in Group 1 if they meet the conditions in C above: 1. Those constructed entirely from a single prokaryotic recipient (including its indigenous plasmids and viruses) or from a single eukaryotic recipient (including its chloroplats, mitochondria, plasmids, but excluding viruses). 2. Those that consist entirely of genetic sequences from different species that exchange these sequences by known physiological processes(or cell-line) or into cells of phylogenetically closely related species which can naturally exchange genetic material with the donor species.
( 1 ) OJ No L 117, 8. 5. 1990, p. 1.